Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered and Regional Scope
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders
1.6 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation Methodology
2.2.1 Precision Diagnostics Market
2.2.2 Precision Medicine Market
2.2.3 Insights from Primary Sources
2.3 Top-Down Approach
2.3.1 Precision Diagnostics Market
2.3.2 Precision Medicine Market
2.4 Growth Forecast Model
2.5 Market Breakdown and Data Triangulation
2.6 Research Assumptions
2.7 Research Limitations
2.8 Risk Analysis

4.1 Precision Diagnostics Market Overview
4.2 Precision Medicine Market Overview
4.3 North America: Precision Diagnostics Market, by Type and Country, 2023
4.4 Precision Diagnostics Market, by Indication, 2024 vs. 2029
4.5 Precision Diagnostics Market, by End-user, 2023
4.6 North America: Precision Medicine Market, by Product and Country, 2023
4.7 Precision Medicine Market, by Indication, 2024 vs. 2029
4.8 Precision Diagnostics Market: Geographic Growth Opportunities
4.9 Precision Medicine Market: Geographic Growth Opportunities

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Collaborations Between Pharmaceutical and Diagnostic Companies
5.2.1.2 Rise in Direct-To-Consumer Testing
5.2.1.3 Growing Integration of Artificial Intelligence and Machine Learning
5.2.2 Restraints
5.2.2.1 High Cost of Precision Healthcare
5.2.3 Opportunities
5.2.3.1 Expanding Applications of Precision Healthcare
5.2.3.2 Growing Adoption of Wearable Devices
5.2.4 Challenges
5.2.4.1 Complex Regulatory Approval Landscape
5.2.4.2 Big Data Management and Integration Issues
5.3 Trends/Disruptions Impacting Customer Business
5.4 Pricing Analysis
5.4.1 Average Selling Price Trend, by Key Player
5.4.2 Average Selling Price Trend of Precision Medicine Products, by Key Player
5.4.3 Average Selling Price Trend, by Region
5.5 Value Chain Analysis
5.5.1 Precision Diagnostics Market
5.5.2 Precision Medicine Market
5.6 Supply Chain Analysis
5.6.1 Precision Diagnostics Market
5.6.2 Precision Medicine Market
5.7 Ecosystem Analysis
5.8 Pipeline Analysis
5.9 Diagnostic Product Analysis
5.10 Investment/Funding Activity
5.11 Technology Analysis
5.11.1 Key Technologies
5.11.1.1 Next-Generation Sequencing
5.11.1.2 Immunohistochemistry
5.11.1.3 Liquid Biopsy
5.11.2 Complementary Technologies
5.11.2.1 Single-Cell Analysis
5.11.2.2 AI and ML Integration
5.11.3 Adjacent Technologies
5.11.3.1 Theranostics
5.11.3.2 Imaging Technologies
5.12 Patent Analysis
5.13 Trade Analysis
5.13.1 Import Data
5.13.2 Export Data
5.14 Key Conferences and Events, 2025-2026
5.15 Regulatory Landscape
5.15.1 Regulatory Analysis
5.15.1.1 North America
5.15.1.2 Europe
5.15.1.3 Asia-Pacific
5.15.1.4 Rest of the World
5.15.2 Regulatory Bodies, Government Agencies, and Other Organizations
5.16 Porter's Five Forces Analysis
5.16.1 Precision Diagnostics Market
5.16.1.1 Threat of New Entrants
5.16.1.2 Threat of Substitutes
5.16.1.3 Bargaining Power of Buyers
5.16.1.4 Bargaining Power of Suppliers
5.16.1.5 Intensity of Competitive Rivalry
5.16.2 Precision Medicine Market
5.16.2.1 Threat of New Entrants
5.16.2.2 Threat of Substitutes
5.16.2.3 Bargaining Power of Buyers
5.16.2.4 Bargaining Power of Suppliers
5.16.2.5 Intensity of Competitive Rivalry
5.17 Key Stakeholders and Buying Criteria
5.17.1 Key Stakeholders in Buying Process
5.17.2 Buying Criteria
5.18 Impact of AI/Gen AI on Precision Diagnostics and Medicine Market
5.18.1 Introduction
5.18.2 Market Potential of Precision Diagnostics and Medicines
5.18.3 AI Use Cases
5.18.4 Key Companies Implementing AI
5.18.5 Future of Generative AI on Precision Diagnostics and Medicine Ecosystem

6.1 Introduction
6.2 Genetic Testing
6.2.1 Need to Detect Hereditary and Rare Diseases to Stimulate Growth
6.3 Dtc Testing
6.3.1 Increased Awareness About Personalized Health to Encourage Growth
6.4 Other Types

7.1 Introduction
7.2 Oncology
7.2.1 Rising Cancer Cases to Accelerate Growth
7.3 Neurology
7.3.1 Increasing Development of Precision Diagnostic Tests for Neurological Diseases to Fuel Market
7.4 Immunology
7.4.1 Growing Integration of Artificial Intelligence and Machine Learning in Diagnostic Tools to Drive Market
7.5 Other Diagnostic Indications

8.1 Introduction
8.2 Clinical Laboratories
8.2.1 Rising Demand for Personalized Medicine to Facilitate Growth
8.3 Hospitals
8.3.1 Growing Collaborations Among Diagnostic Manufacturing Companies to Drive Market
8.4 Home Care Settings
8.4.1 Increasing Demand for At-Home Diagnostic Tests to Spur Growth

9.1 Introduction
9.2 Monoclonal Antibodies
9.2.1 Rising Adoption of Oncology and Autoimmune Therapies to Support Growth
9.3 Inhibitor Drugs
9.3.1 Increasing Fda Approvals for Novel Inhibitors to Contribute to Growth
9.4 Cell & Gene Therapies
9.4.1 Growing Investments in Genetic Disorder Research to Fuel Market
9.5 Antiviral & Anti-Retroviral Drugs
9.5.1 Need to Target Viral Infections and Prevent Virus Spread to Facilitate Growth
9.6 Other Products

10.1 Introduction
10.2 Oncology
10.2.1 Growing Emphasis on Developing Precision Cancer Therapies to Boost Market
10.3 Rare Diseases
10.3.1 Shifting Focus on Targeted Treatment to Favor Growth
10.4 Infectious Diseases
10.4.1 Need to Enhance Efficacy of Treatments to Drive Market
10.5 Hematological Disorders
10.5.1 Increasing Research on Developing Personalized Therapies to Augment Growth
10.6 Other Medicine Indications

11.1 Introduction
11.2 Hospitals & Clinics
11.2.1 Growing Focus on Precision Therapies to Fuel Market
11.3 Home Care Settings
11.3.1 Increasing Preference for Self-Administration Techniques to Expedite Growth

12.1 Introduction
12.2 North America
12.2.1 Macroeconomic Outlook for North America
12.2.2 US
12.2.2.1 Well-Established Infrastructure and Availability of Advanced Treatments to Augment Growth
12.2.3 Canada
12.2.3.1 Growing Cancer Burden to Support Growth
12.3 Europe
12.3.1 Macroeconomic Outlook for Europe
12.3.2 Germany
12.3.2.1 Growing Collaborations Between Research Institutions and Healthcare Providers to Boost Market
12.3.3 UK
12.3.3.1 Favorable Government Support to Expedite Growth
12.3.4 France
12.3.4.1 Growing Preference for Personalized Medicine to Fuel Market
12.3.5 Italy
12.3.5.1 Rise in Genomics Research and Diagnostic Testing to Foster Growth.
12.3.6 Spain
12.3.6.1 Robust Network of Healthcare Systems, Research Centers, and Universities to Facilitate Growth
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Macroeconomic Outlook for Asia-Pacific
12.4.2 China
12.4.2.1 Growing Regulatory Approvals for Precision Medicines to Boost Market
12.4.3 Japan
12.4.3.1 Increasing Availability of Health Insurance to Encourage Growth
12.4.4 India
12.4.4.1 Rising Burden of Chronic Diseases to Promote Growth
12.4.5 Australia
12.4.5.1 Booming Research & Development Investments to Spur Growth
12.4.6 Rest of Asia-Pacific
12.5 Latin America
12.5.1 Macroeconomic Outlook for Latin America
12.5.2 Brazil
12.5.2.1 Growing Incorporation of Genomic Medicine into Public Healthcare to Drive Market
12.5.3 Mexico
12.5.3.1 Booming Biopharmaceutical Sector to Contribute to Growth
12.5.4 Rest of Latin America
12.6 Middle East & Africa
12.6.1 Macroeconomic Outlook for Middle East & Africa

13.1 Overview
13.2 Key Player Strategies/Right to Win, 2021-2024
13.2.1 Precision Diagnostics Market
13.2.2 Precision Medicine Market
13.3 Revenue Analysis, 2021-2023
13.3.1 Precision Diagnostics Market
13.3.2 Precision Medicine Market
13.4 Market Share Analysis, 2023
13.4.1 Precision Diagnostics Market
13.4.2 Precision Medicine Market
13.5 Company Evaluation Matrix: Key Players, 2023
13.5.1 Precision Diagnostics Market
13.5.1.1 Stars
13.5.1.2 Emerging Leaders
13.5.1.3 Pervasive Players
13.5.1.4 Participants
13.5.1.5 Company Footprint: Key Players, 2023
13.5.1.5.1 Company Footprint
13.5.1.5.2 Region Footprint
13.5.1.5.3 Type Footprint
13.5.1.5.4 Indication Footprint
13.5.2 Precision Medicine Market
13.5.2.1 Stars
13.5.2.2 Emerging Leaders
13.5.2.3 Pervasive Players
13.5.2.4 Participants
13.5.2.5 Company Footprint: Key Players, 2023
13.5.2.5.1 Company Footprint
13.5.2.5.2 Region Footprint
13.5.2.5.3 Product Footprint
13.5.2.5.4 Indication Footprint
13.6 Company Evaluation Matrix: Startups/SMEs, 2023
13.6.1 Precision Diagnostics Market
13.6.1.1 Progressive Companies
13.6.1.2 Responsive Companies
13.6.1.3 Dynamic Companies
13.6.1.4 Starting Blocks
13.6.1.5 Competitive Benchmarking
13.6.1.5.1 Detailed List of Key Startups/SMEs
13.6.1.5.2 Competitive Benchmarking of Startups/SMEs
13.6.2 Precision Medicine Market
13.6.2.1 Progressive Companies
13.6.2.2 Responsive Companies
13.6.2.3 Dynamic Companies
13.6.2.4 Starting Blocks
13.6.2.5 Competitive Benchmarking
13.6.2.5.1 Detailed List of Key Startups/SMEs
13.6.2.5.2 Competitive Benchmarking of Startups/SMEs
13.7 Company Valuation and Financial Metrics
13.7.1 Precision Diagnostics Market
13.7.2 Precision Medicine Market
13.8 Brand/Product Comparison
13.9 Precision Diagnostics Market: Competitive Scenario
13.9.1 Product Launches and Approvals
13.9.2 Deals
13.9.3 Expansions
13.10 Precision Medicine Market: Competitive Scenario
13.10.1 Product Launches and Approvals
13.10.2 Deals
13.10.3 Expansions

14.1 Key Players
14.1.1 F. Hoffmann-La Roche Ltd (Diagnostics)
14.1.1.1 Business Overview
14.1.1.2 Products Offered
14.1.1.3 Recent Developments
14.1.1.3.1 Product Launches and Approvals
14.1.1.3.2 Deals
14.1.1.4 Analyst's View
14.1.1.4.1 Key Strengths
14.1.1.4.2 Strategic Choices
14.1.1.4.3 Weaknesses and Competitive Threats
14.1.2 Abbott
14.1.2.1 Business Overview
14.1.2.2 Products Offered
14.1.2.3 Recent Developments
14.1.2.3.1 Deals
14.1.2.4 Analyst's View
14.1.2.4.1 Key Strengths
14.1.2.4.2 Strategic Choices
14.1.2.4.3 Weaknesses and Competitive Threats
14.1.3 Agilent Technologies, Inc.
14.1.3.1 Business Overview
14.1.3.2 Products Offered
14.1.3.3 Recent Developments
14.1.3.3.1 Product Launches and Approvals
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 Analyst's View
14.1.3.4.1 Key Strengths
14.1.3.4.2 Strategic Choices
14.1.3.4.3 Weaknesses and Competitive Threats
14.1.4 Guardant Health
14.1.4.1 Business Overview
14.1.4.2 Products Offered
14.1.4.3 Recent Developments
14.1.4.3.1 Product Launches and Approvals
14.1.4.3.2 Deals
14.1.4.4 Analyst's View
14.1.4.4.1 Key Strengths
14.1.4.4.2 Strategic Choices
14.1.4.4.3 Weaknesses and Competitive Threats
14.1.5 Exact Sciences Corporation
14.1.5.1 Business Overview
14.1.5.2 Products Offered
14.1.5.3 Recent Developments
14.1.5.3.1 Product Launches and Approvals
14.1.5.3.2 Deals
14.1.5.4 Analyst's View
14.1.5.4.1 Key Strengths
14.1.5.4.2 Strategic Choices
14.1.5.4.3 Weaknesses and Competitive Threats
14.1.6 Qiagen
14.1.6.1 Business Overview
14.1.6.2 Products Offered
14.1.6.3 Recent Developments
14.1.6.3.1 Product Launches and Approvals
14.1.6.3.2 Deals
14.1.7 Myriad Genetics, Inc.
14.1.7.1 Business Overview
14.1.7.2 Products Offered
14.1.7.3 Recent Developments
14.1.7.3.1 Product Launches and Approvals
14.1.7.3.2 Deals
14.1.7.3.3 Other Developments
14.1.8 Natera, Inc.
14.1.8.1 Business Overview
14.1.8.2 Products Offered
14.1.8.3 Recent Developments
14.1.8.3.1 Product Launches and Approvals
14.1.8.3.2 Deals
14.1.9 Illumina, Inc.
14.1.9.1 Business Overview
14.1.9.2 Products Offered
14.1.9.3 Recent Developments
14.1.9.3.1 Product Launches and Approvals
14.1.9.3.2 Deals
14.1.10 Thermo Fisher Scientific Inc.
14.1.10.1 Business Overview
14.1.10.2 Products Offered
14.1.10.3 Recent Developments
14.1.10.3.1 Product Launches and Approvals
14.1.10.3.2 Deals
14.1.11 Danaher
14.1.11.1 Business Overview
14.1.11.2 Products Offered
14.1.11.3 Recent Developments
14.1.11.3.1 Product Launches and Approvals
14.1.11.3.2 Deals
14.1.12 23Andme, Inc.
14.1.12.1 Business Overview
14.1.12.2 Products Offered
14.1.12.3 Recent Developments
14.1.12.3.1 Deals
14.1.13 Merck & Co. Inc.
14.1.13.1 Business Overview
14.1.13.2 Products Offered
14.1.13.3 Recent Developments
14.1.13.3.1 Product Launches and Approvals
14.1.13.3.2 Deals
14.1.14 Gilead Sciences, Inc.
14.1.14.1 Business Overview
14.1.14.2 Products Offered
14.1.14.3 Recent Developments
14.1.14.3.1 Product Launches and Approvals
14.1.14.3.2 Deals
14.1.15 F. Hoffmann-La Roche Ltd (Medicine)
14.1.15.1 Business Overview
14.1.15.2 Products Offered
14.1.15.3 Recent Developments
14.1.15.3.1 Product Launches and Approvals
14.1.16 Bristol-Myers Squibb Company
14.1.16.1 Business Overview
14.1.16.2 Products Offered
14.1.16.3 Recent Developments
14.1.16.3.1 Product Launches and Approvals
14.1.16.3.2 Deals
14.1.17 Novartis AG
14.1.17.1 Business Overview
14.1.17.2 Products Offered
14.1.17.3 Recent Developments
14.1.17.3.1 Product Launches and Approvals
14.1.17.3.2 Deals
14.1.18 Astrazeneca
14.1.18.1 Business Overview
14.1.18.2 Products Offered
14.1.18.3 Recent Developments
14.1.18.3.1 Product Launches and Approvals
14.1.18.3.2 Deals
14.1.19 Abbvie Inc.
14.1.19.1 Business Overview
14.1.19.2 Products Offered
14.1.19.3 Recent Developments
14.1.19.3.1 Product Launches and Approvals
14.1.19.3.2 Deals
14.1.19.3.3 Expansions
14.1.20 Lilly
14.1.20.1 Business Overview
14.1.20.2 Products Offered
14.1.20.3 Recent Developments
14.1.20.3.1 Product Launches and Approvals
14.1.20.3.2 Deals
14.1.21 Pfizer Inc.
14.1.21.1 Business Overview
14.1.21.2 Products Offered
14.1.21.3 Recent Developments
14.1.21.3.1 Product Launches and Approvals
14.1.21.3.2 Deals
14.1.22 Sarepta Therapeutics, Inc.
14.1.22.1 Business Overview
14.1.22.2 Products Offered
14.1.22.3 Recent Developments
14.1.22.3.1 Product Launches and Approvals
14.1.22.3.2 Deals
14.1.23 Vertex Pharmaceuticals Incorporated
14.1.23.1 Business Overview
14.1.23.2 Products Offered
14.1.23.3 Recent Developments
14.1.23.3.1 Product Launches and Approvals
14.1.23.3.2 Deals
14.1.24 Gsk PLC.
14.1.24.1 Business Overview
14.1.24.2 Products Offered
14.1.24.3 Recent Developments
14.1.24.3.1 Product Launches and Approvals
14.1.24.3.2 Deals
14.2 Other Players
14.2.1 Sanofi
14.2.2 Johnson & Johnson Services, Inc.
14.2.3 Amgen Inc.
14.2.4 Merck KGaA
14.2.5 Alnylam Pharmaceuticals, Inc.
14.2.6 Incyte
14.2.7 Arup Laboratories
14.2.8 Devyser
14.2.9 Diasorin S.P.A.
14.2.10 Tempus
14.2.11 Pillar Biosciences Inc.
14.2.12 Invivoscribe, Inc.
14.2.13 Neurocode
14.2.14 C2N Diagnostics
14.2.15 Trinity Biotech
14.2.16 Amoy Diagnostics Co. Ltd.

15.1 Discussion Guide
15.2 Knowledgestore: The Subscription Portal
15.3 Customization Options

Table 1 Precision Diagnostics and Medicine Market: Inclusions and Exclusions
Table 2 Precision Diagnostics and Medicine Market: Risk Assessment
Table 3 Precision Diagnostics and Medicine Market: Impact Analysis of Market Dynamics
Table 4 Average Selling Price Trend of Precision Diagnostic Tests, by Key Player, 2021-2023 (USD)
Table 5 Average Selling Price Trend of Precision Medicine Products, by Key Player, 2021-2023 (USD)
Table 6 Average Selling Price Trend of Precision Medicine Products, by Region, 2021-2023 (USD)
Table 7 Precision Diagnostics and Medicine Market: Role of Companies in Ecosystem
Table 8 Precision Medicine Products in Clinical Pipeline, 2025-2029
Table 9 Precision Diagnostic Tests Approved by Fda
Table 10 Precision Diagnostic Products Analysis
Table 11 Patents Filed, by Document Type, 2014-2024
Table 12 Precision Diagnostics and Medicine Market: Innovations and Patent Registrations, 2019-2024
Table 13 Import Data for Diagnostic or Laboratory Reagents for HS Code 382200, 2019-2023 (USD Thousand)
Table 14 Import Data for Diagnostic or Laboratory Reagents for HS Code 382200, 2019-2023 (Tons)
Table 15 Export Data for Diagnostic or Laboratory Reagents for HS Code 382200, 2019-2023 (USD Thousand)
Table 16 Export Data for Diagnostic or Laboratory Reagents for HS Code 382200, 2019-2023 (Tons)
Table 17 Precision Diagnostics and Medicine Market: Key Conferences and Events, 2025-2026
Table 18 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 19 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 20 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 21 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 22 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
Table 23 Precision Diagnostics Market: Porter's Five Forces Analysis
Table 24 Precision Medicine Market: Porter's Five Forces Analysis
Table 25 Influence of Stakeholders on Buying Process of Precision Diagnostic Products, by Type
Table 26 Influence of Stakeholders on Buying Process of Precision Medicine Products, by Product
Table 27 Buying Criteria for Precision Diagnostic Products, by End-user
Table 28 Buying Criteria for Precision Medicine Products, by End-user
Table 29 Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 30 Precision Diagnostics Market for Genetic Testing, by Region, 2022-2029 (USD Billion)
Table 31 North America: Precision Diagnostics Market for Genetic Testing, by Country, 2022-2029 (USD Billion)
Table 32 Europe: Precision Diagnostics Market for Genetic Testing, by Country, 2022-2029 (USD Billion)
Table 33 Asia-Pacific: Precision Diagnostics Market for Genetic Testing, by Country, 2022-2029 (USD Billion)
Table 34 Latin America: Precision Diagnostics Market for Genetic Testing, by Country, 2022-2029 (USD Billion)
Table 35 Precision Diagnostics Market for Dtc Testing, by Region, 2022-2029 (USD Billion)
Table 36 North America: Precision Diagnostics Market for Dtc Testing, by Country, 2022-2029 (USD Billion)
Table 37 Europe: Precision Diagnostics Market for Dtc Testing, by Country, 2022-2029 (USD Billion)
Table 38 Asia-Pacific: Precision Diagnostics Market for Dtc Testing, by Country, 2022-2029 (USD Billion)
Table 39 Latin America: Precision Diagnostics Market for Dtc Testing, by Country, 2022-2029 (USD Billion)
Table 40 Precision Diagnostics Market for Other Types, by Region, 2022-2029 (USD Billion)
Table 41 North America: Precision Diagnostics Market for Other Types, by Country, 2022-2029 (USD Billion)
Table 42 Europe: Precision Diagnostics Market for Other Types, by Country, 2022-2029 (USD Billion)
Table 43 Asia-Pacific: Precision Diagnostics Market for Other Types, by Country, 2022-2029 (USD Billion)
Table 44 Latin America: Precision Diagnostics Market for Other Types, by Country, 2022-2029 (USD Billion)
Table 45 Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 46 Precision Diagnostics Market for Oncology, by Region, 2022-2029 (USD Billion)
Table 47 North America: Precision Diagnostics Market for Oncology, by Country, 2022-2029 (USD Billion)
Table 48 Europe: Precision Diagnostics Market for Oncology, by Country, 2022-2029 (USD Billion)
Table 49 Asia-Pacific: Precision Diagnostics Market for Oncology, by Country, 2022-2029 (USD Billion)
Table 50 Latin America: Precision Diagnostics Market for Oncology, by Country, 2022-2029 (USD Billion)
Table 51 Precision Diagnostics Market for Neurology, by Region, 2022-2029 (USD Billion)
Table 52 North America: Precision Diagnostics Market for Neurology, by Country, 2022-2029 (USD Billion)
Table 53 Europe: Precision Diagnostics Market for Neurology, by Country, 2022-2029 (USD Billion)
Table 54 Asia-Pacific: Precision Diagnostics Market for Neurology, by Country, 2022-2029 (USD Billion)
Table 55 Latin America: Precision Diagnostics Market for Neurology, by Country, 2022-2029 (USD Billion)
Table 56 Precision Diagnostics Market for Immunology, by Region, 2022-2029 (USD Billion)
Table 57 North America: Precision Diagnostics Market for Immunology, by Country, 2022-2029 (USD Billion)
Table 58 Europe: Precision Diagnostics Market for Immunology, by Country, 2022-2029 (USD Billion)
Table 59 Asia-Pacific: Precision Diagnostics Market for Immunology, by Country, 2022-2029 (USD Billion)
Table 60 Latin America: Precision Diagnostics Market for Immunology, by Country, 2022-2029 (USD Billion)
Table 61 Precision Diagnostics Market for Other Diagnostic Indications, by Region, 2022-2029 (USD Billion)
Table 62 North America: Precision Diagnostics Market for Other Diagnostic Indications, by Country, 2022-2029 (USD Billion)
Table 63 Europe: Precision Diagnostics Market for Other Diagnostic Indications, by Country, 2022-2029 (USD Billion)
Table 64 Asia-Pacific: Precision Diagnostics Market for Other Diagnostic Indications, by Country, 2022-2029 (USD Billion)
Table 65 Latin America: Precision Diagnostics Market for Other Diagnostic Indications, by Country, 2022-2029 (USD Billion)
Table 66 Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 67 Precision Diagnostics Market for Clinical Laboratories, by Region, 2022-2029 (USD Billion)
Table 68 North America: Precision Diagnostics Market for Clinical Laboratories, by Country, 2022-2029 (USD Billion)
Table 69 Europe: Precision Diagnostics Market for Clinical Laboratories, by Country, 2022-2029 (USD Billion)
Table 70 Asia-Pacific: Precision Diagnostics Market for Clinical Laboratories, by Country, 2022-2029 (USD Billion)
Table 71 Latin America: Precision Diagnostics Market for Clinical Laboratories, by Country, 2022-2029 (USD Billion)
Table 72 Precision Diagnostics Market for Hospitals, by Region, 2022-2029 (USD Billion)
Table 73 North America: Precision Diagnostics Market for Hospitals, by Country, 2022-2029 (USD Billion)
Table 74 Europe: Precision Diagnostics Market for Hospitals, by Country, 2022-2029 (USD Billion)
Table 75 Asia-Pacific: Precision Diagnostics Market for Hospitals, by Country, 2022-2029 (USD Billion)
Table 76 Latin America: Precision Diagnostics Market for Hospitals, by Country, 2022-2029 (USD Billion)
Table 77 Precision Diagnostics Market for Home Care Settings, by Region, 2022-2029 (USD Billion)
Table 78 North America: Precision Diagnostics Market for Home Care Settings, by Country, 2022-2029 (USD Billion)
Table 79 Europe: Precision Diagnostics Market for Home Care Settings, by Country, 2022-2029 (USD Billion)
Table 80 Asia-Pacific: Precision Diagnostics Market for Home Care Settings, by Country, 2022-2029 (USD Billion)
Table 81 Latin America: Precision Diagnostics Market for Home Care Settings, by Country, 2022-2029 (USD Billion)
Table 82 Precision Medicine Market, by Type, 2022-2029 (USD Billion)
Table 83 Precision Medicine Market for Monoclonal Antibodies, by Region, 2022-2029 (USD Billion)
Table 84 North America: Precision Medicine Market for Monoclonal Antibodies, by Country, 2022-2029 (USD Billion)
Table 85 Europe: Precision Medicine Market for Monoclonal Antibodies, by Country, 2022-2029 (USD Billion)
Table 86 Asia-Pacific: Precision Medicine Market for Monoclonal Antibodies, by Country, 2022-2029 (USD Billion)
Table 87 Latin America: Precision Medicine Market for Monoclonal Antibodies, by Country, 2022-2029 (USD Billion)
Table 88 Precision Medicine Market for Inhibitor Drugs, by Region, 2022-2029 (USD Billion)
Table 89 North America: Precision Medicine Market for Inhibitor Drugs, by Country, 2022-2029 (USD Billion)
Table 90 Europe: Precision Medicine Market for Inhibitor Drugs, by Country, 2022-2029 (USD Billion)
Table 91 Asia-Pacific: Precision Medicine Market for Inhibitor Drugs, by Country, 2022-2029 (USD Billion)
Table 92 Latin America: Precision Medicine Market for Inhibitor Drugs, by Country, 2022-2029 (USD Billion)
Table 93 Precision Medicine Market for Cell & Gene Therapies, by Region, 2022-2029 (USD Billion)
Table 94 North America: Precision Medicine Market for Cell & Gene Therapies, by Country, 2022-2029 (USD Billion)
Table 95 Europe: Precision Medicine Market for Cell & Gene Therapies, by Country, 2022-2029 (USD Billion)
Table 96 Asia-Pacific: Precision Medicine Market for Cell & Gene Therapies, by Country, 2022-2029 (USD Billion)
Table 97 Latin America: Precision Medicine Market for Cell & Gene Therapies, by Country, 2022-2029 (USD Billion)
Table 98 Precision Medicine Market for Antiviral & Anti-Retroviral Drugs, by Region, 2022-2029 (USD Billion)
Table 99 North America: Precision Medicine Market for Antiviral & Anti-Retroviral Drugs, by Country, 2022-2029 (USD Billion)
Table 100 Europe: Precision Medicine Market for Antiviral & Anti-Retroviral Drugs, by Country, 2022-2029 (USD Billion)
Table 101 Asia-Pacific: Precision Medicine Market for Antiviral & Anti-Retroviral Drugs, by Country, 2022-2029 (USD Billion)
Table 102 Latin America: Precision Medicine Market for Antiviral & Anti-Retroviral Drugs, by Country, 2022-2029 (USD Billion)
Table 103 Precision Medicine Market for Other Products, by Region, 2022-2029 (USD Billion)
Table 104 North America: Precision Medicine Market for Other Products, by Country, 2022-2029 (USD Billion)
Table 105 Europe: Precision Medicine Market for Other Products, by Country, 2022-2029 (USD Billion)
Table 106 Asia-Pacific: Precision Medicine Market for Other Products, by Country, 2022-2029 (USD Billion)
Table 107 Latin America: Precision Medicine Market for Other Products, by Country, 2022-2029 (USD Billion)
Table 108 Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 109 Precision Medicine Market for Oncology, by Region, 2022-2029 (USD Billion)
Table 110 North America: Precision Medicine Market for Oncology, by Country, 2022-2029 (USD Billion)
Table 111 Europe: Precision Medicine Market for Oncology, by Country, 2022-2029 (USD Billion)
Table 112 Asia-Pacific: Precision Medicine Market for Oncology, by Country, 2022-2029 (USD Billion)
Table 113 Latin America: Precision Medicine Market for Oncology, by Country, 2022-2029 (USD Billion)
Table 114 Precision Medicine Market for Rare Diseases, by Region, 2022-2029 (USD Billion)
Table 115 North America: Precision Medicine Market for Rare Diseases, by Country, 2022-2029 (USD Billion)
Table 116 Europe: Precision Medicine Market for Rare Diseases, by Country, 2022-2029 (USD Billion)
Table 117 Asia-Pacific: Precision Medicine Market for Rare Diseases, by Country, 2022-2029 (USD Billion)
Table 118 Latin America: Precision Medicine Market for Rare Diseases, by Country, 2022-2029 (USD Billion)
Table 119 Precision Medicine Market for Infectious Diseases, by Region, 2022-2029 (USD Billion)
Table 120 North America: Precision Medicine Market for Infectious Diseases, by Country, 2022-2029 (USD Billion)
Table 121 Europe: Precision Medicine Market for Infectious Diseases, by Country, 2022-2029 (USD Billion)
Table 122 Asia-Pacific: Precision Medicine Market for Infectious Diseases, by Country, 2022-2029 (USD Billion)
Table 123 Latin America: Precision Medicine Market for Infectious Diseases, by Country, 2022-2029 (USD Billion)
Table 124 Precision Medicine Market for Hematological Disorders, by Region, 2022-2029 (USD Billion)
Table 125 North America: Precision Medicine Market for Hematological Disorders, by Country, 2022-2029 (USD Billion)
Table 126 Europe: Precision Medicine Market for Hematological Disorders, by Country, 2022-2029 (USD Billion)
Table 127 Asia-Pacific: Precision Medicine Market for Hematological Disorders, by Country, 2022-2029 (USD Billion)
Table 128 Latin America: Precision Medicine Market for Hematological Disorders, by Country, 2022-2029 (USD Billion)
Table 129 Precision Medicine Market for Other Medicine Indications, by Region, 2022-2029 (USD Billion)
Table 130 North America: Precision Medicine Market for Other Medicine Indications, by Country, 2022-2029 (USD Billion)
Table 131 Europe: Precision Medicine Market for Other Medicine Indications, by Country, 2022-2029 (USD Billion)
Table 132 Asia-Pacific: Precision Medicine Market for Other Medicine Indications, by Country, 2022-2029 (USD Billion)
Table 133 Latin America: Precision Medicine Market for Other Medicine Indications, by Country, 2022-2029 (USD Billion)
Table 134 Precision Medicine Market, by End-user, 2022-2029 (USD Million)
Table 135 Precision Medicine Market for Hospitals & Clinics, by Region, 2022-2029 (USD Million)
Table 136 North America: Precision Medicine Market for Hospitals & Clinics, by Country, 2022-2029 (USD Million)
Table 137 Europe: Precision Medicine Market for Hospitals & Clinics, by Country, 2022-2029 (USD Million)
Table 138 Asia-Pacific: Precision Medicine Market for Hospitals & Clinics, by Country, 2022-2029 (USD Million)
Table 139 Latin America: Precision Medicine Market for Hospitals & Clinics, by Country, 2022-2029 (USD Million)
Table 140 Precision Medicine Market for Home Care Settings, by Region, 2022-2029 (USD Million)
Table 141 North America: Precision Medicine Market for Home Care Settings, by Country, 2022-2029 (USD Million)
Table 142 Europe: Precision Medicine Market for Home Care Settings, by Country, 2022-2029 (USD Million)
Table 143 Asia-Pacific: Precision Medicine Market for Home Care Settings, by Country, 2022-2029 (USD Million)
Table 144 Latin America: Precision Medicine Market for Home Care Settings, by Country, 2022-2029 (USD Million)
Table 145 Precision Diagnostics and Medicine Market, by Region, 2022-2029 (USD Billion)
Table 146 North America: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 147 North America: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 148 North America: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 149 North America: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 150 North America: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 151 North America: Precision Medicine Market, End-user, 2022-2029 (USD Billion)
Table 152 North America: Precision Diagnostics Market, by Country, 2022-2029 (USD Billion)
Table 153 North America: Precision Medicine Market, by Country, 2022-2029 (USD Billion)
Table 154 North America: Key Macroeconomic Indicators
Table 155 US: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 156 US: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 157 US: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 158 US: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 159 US: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 160 US: Precision Medicine Market, End-user, 2022-2029 (USD Billion)
Table 161 Canada: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 162 Canada: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 163 Canada: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 164 Canada: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 165 Canada: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 166 Canada: Precision Medicine Market, End-user, 2022-2029 (USD Billion)
Table 167 Europe: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 168 Europe: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 169 Europe: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 170 Europe: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 171 Europe: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 172 Europe: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 173 Europe: Precision Diagnostics Market, by Country, 2022-2029 (USD Billion)
Table 174 Europe: Precision Medicine Market, by Country, 2022-2029 (USD Billion)
Table 175 Europe: Key Macroeconomic Indicators
Table 176 Germany: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 177 Germany: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 178 Germany: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 179 Germany: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 180 Germany: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 181 Germany: Precision Medicine Market, End-user, 2022-2029 (USD Billion)
Table 182 UK: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 183 UK: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 184 UK: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 185 UK: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 186 UK: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 187 UK: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 188 France: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 189 France: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 190 France: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 191 France: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 192 France: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 193 France: Precision Medicine Market, End-user, 2022-2029 (USD Billion)
Table 194 Italy: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 195 Italy: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 196 Italy: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 197 Italy: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 198 Italy: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 199 Italy: Precision Medicine Market, End-user, 2022-2029 (USD Billion)
Table 200 Spain: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 201 Spain: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 202 Spain: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 203 Spain: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 204 Spain: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 205 Spain: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 206 Rest of Europe: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 207 Rest of Europe: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 208 Rest of Europe: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 209 Rest of Europe: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 210 Rest of Europe: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 211 Rest of Europe: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 212 Asia-Pacific: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 213 Asia-Pacific: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 214 Asia-Pacific: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 215 Asia-Pacific: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 216 Asia-Pacific: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 217 Asia-Pacific: Precision Medicine Market, End-user, 2022-2029 (USD Billion)
Table 218 Asia-Pacific: Precision Diagnostics Market, by Country, 2022-2029 (USD Billion)
Table 219 Asia-Pacific: Precision Medicine Market, by Country, 2022-2029 (USD Billion)
Table 220 Asia-Pacific: Key Macroeconomic Indicators
Table 221 China: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 222 China: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 223 China: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 224 China: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 225 China: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 226 China: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 227 Japan: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 228 Japan: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 229 Japan: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 230 Japan: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 231 Japan: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 232 Japan: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 233 India: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 234 India: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 235 India: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 236 India: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 237 India: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 238 India: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 239 Australia: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 240 Australia: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 241 Australia: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 242 Australia: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 243 Australia: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 244 Australia: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 245 Rest of Asia-Pacific: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 246 Rest of Asia-Pacific: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 247 Rest of Asia-Pacific: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 248 Rest of Asia-Pacific: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 249 Rest of Asia-Pacific: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 250 Rest of Asia-Pacific: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 251 Latin America: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 252 Latin America: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 253 Latin America: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 254 Latin America: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 255 Latin America: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 256 Latin America: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 257 Latin America: Precision Diagnostics Market, by Country, 2022-2029 (USD Billion)
Table 258 Latin America: Precision Medicine Market, by Country, 2022-2029 (USD Billion)
Table 259 Latin America: Key Macroeconomic Indicators
Table 260 Brazil: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 261 Brazil: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 262 Brazil: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 263 Brazil: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 264 Brazil: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 265 Brazil: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 266 Mexico: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 267 Mexico: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 268 Mexico: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 269 Mexico: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 270 Mexico: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 271 Mexico: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 272 Rest of Latin America: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 273 Rest of Latin America: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 274 Rest of Latin America: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 275 Rest of Latin America: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 276 Rest of Latin America: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 277 Rest of Latin America: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 278 Middle East & Africa: Precision Diagnostics Market, by Type, 2022-2029 (USD Billion)
Table 279 Middle East & Africa: Precision Diagnostics Market, by Indication, 2022-2029 (USD Billion)
Table 280 Middle East & Africa: Precision Diagnostics Market, by End-user, 2022-2029 (USD Billion)
Table 281 Middle East & Africa: Precision Medicine Market, by Product, 2022-2029 (USD Billion)
Table 282 Middle East & Africa: Precision Medicine Market, by Indication, 2022-2029 (USD Billion)
Table 283 Middle East & Africa: Precision Medicine Market, by End-user, 2022-2029 (USD Billion)
Table 284 Middle East & Africa: Key Macroeconomic Indicators
Table 285 Overview of Strategies Adopted by Key Players in Precision Diagnostics Market, January 2021-November 2024
Table 286 Overview of Strategies Adopted by Key Players in Precision Medicine Market, January 2021-November 2024
Table 287 Precision Diagnostics Market: Degree of Competition
Table 288 Precision Medicine Market: Degree of Competition
Table 289 Precision Diagnostics Market: Region Footprint
Table 290 Precision Diagnostics Market: Type Footprint
Table 291 Precision Diagnostics Market: Indication Footprint
Table 292 Precision Medicine Market: Region Footprint
Table 293 Precision Medicine Market: Product Footprint
Table 294 Precision Medicine Market: Indication Footprint
Table 295 Precision Diagnostics Market: Detailed List of Key Startups/SMEs
Table 296 Precision Diagnostics Market: Competitive Benchmarking of Key Startups/SMEs
Table 297 Precision Medicine Market: Detailed List of Key Startups/SMEs
Table 298 Precision Medicine Market: Competitive Benchmarking of Key Startups/SMEs
Table 299 Precision Diagnostics Market: Product Launches and Approvals, January 2021-November 2024
Table 300 Precision Diagnostics Market: Deals, January 2021-November 2024
Table 301 Precision Diagnostics Market: Expansions, January 2021-November 2024
Table 302 Precision Medicine Market: Product Launches and Approvals, January 2021-November 2024
Table 303 Precision Medicine Market: Deals, January 2021-November 2024
Table 304 Precision Medicine: Expansions, January 2021-November 2024
Table 305 F. Hoffmann-La Roche Ltd (Diagnostics): Company Overview
Table 306 F. Hoffmann-La Roche Ltd (Diagnostics): Products Offered
Table 307 F. Hoffmann-La Roche Ltd (Diagnostics): Product Launches and Approvals, January 2021-November 2024
Table 308 F. Hoffmann-La Roche Ltd (Diagnostics): Deals, January 2021-November 2024
Table 309 Abbott: Company Overview
Table 310 Abbott: Products Offered
Table 311 Abbott: Deals, January 2021-November 2024
Table 312 Agilent Technologies, Inc.: Company Overview
Table 313 Agilent Technologies, Inc.: Products Offered
Table 314 Agilent Technologies, Inc.: Product Launches and Approvals, January 2021-November 2024
Table 315 Agilent Technologies, Inc.: Deals, January 2021-November 2024
Table 316 Agilent Technologies, Inc.: Expansions, January 2021-November 2024
Table 317 Guardant Health: Company Overview
Table 318 Guardant Health: Products Offered
Table 319 Guardant Health: Product Launches and Approvals, January 2021-November 2024
Table 320 Guardant Health: Deals, January 2021-November 2024
Table 321 Exact Sciences Corporation: Company Overview
Table 322 Exact Sciences Corporation: Products Offered
Table 323 Exact Sciences Corporation: Product Launches and Approvals, January 2021-November 2024
Table 324 Exact Sciences Corporation: Deals, January 2021-November 2024
Table 325 Qiagen: Company Overview
Table 326 Qiagen: Products Offered
Table 327 Qiagen: Product Launches and Approvals, January 2021-November 2024
Table 328 Qiagen: Deals, January 2021-November 2024
Table 329 Myriad Genetics, Inc.: Company Overview
Table 330 Myriad Genetics, Inc.: Products Offered
Table 331 Myriad Genetics, Inc.: Product Launches and Approvals, January 2021-November 2024
Table 332 Myriad Genetics, Inc.: Deals, January 2021-November 2024
Table 333 Myriad Genetics, Inc.: Other Developments, January 2021-November 2024
Table 334 Natera, Inc.: Company Overview
Table 335 Natera, Inc.: Products Offered
Table 336 Natera, Inc.: Product Launches and Approvals, January 2021-November 2024
Table 337 Natera, Inc.: Deals, January 2021-November 2024
Table 338 Illumina, Inc.: Company Overview
Table 339 Illumina, Inc.: Products Offered
Table 340 Illumina, Inc.: Product Launches and Approvals, January 2021-November 2024
Table 341 Illumina, Inc.: Deals, January 2021-November 2024
Table 342 Thermo Fisher Scientific Inc.: Company Overview
Table 343 Thermo Fisher Scientific Inc.: Products Offered
Table 344 Thermo Fisher Scientific Inc.: Product Launches and Approvals, January 2021-November 2024
Table 345 Thermo Fisher Scientific Inc.: Deals, January 2021-November 2024
Table 346 Danaher: Company Overview
Table 347 Danaher: Products Offered
Table 348 Danaher: Product Launches and Approvals, January 2021-November 2024
Table 349 Danaher: Deals, January 2021-November 2024
Table 350 23Andme, Inc.: Company Overview
Table 351 23Andme, Inc.: Products Offered
Table 352 23Andme, Inc.: Deals, January 2021-November 2024
Table 353 Merck & Co. Inc.: Company Overview
Table 354 Merck & Co. Inc.: Products Offered
Table 355 Merck & Co. Inc.: Product Launches and Approvals, January 2021-December 2024
Table 356 Merck & Co. Inc.: Deals, January 2021-November 2024
Table 357 Gilead Sciences, Inc.: Company Overview
Table 358 Gilead Sciences, Inc.: Products Offered
Table 359 Gilead Sciences, Inc.: Product Launches and Approvals, January 2021-November 2024
Table 360 Gilead Sciences, Inc.: Deals, January 2021-November 2024
Table 361 F. Hoffmann-La Roche Ltd (Medicine): Company Overview
Table 362 F. Hoffmann-La Roche Ltd (Medicine): Products Offered
Table 363 F. Hoffmann-La Roche Ltd (Medicine): Product Launches and Approvals, January 2021-November 2024
Table 364 Bristol-Myers Squibb Company: Company Overview
Table 365 Bristol-Myers Squibb Company: Products Offered
Table 366 Bristol-Myers Squibb Company: Product Launches and Approvals, January 2021-November 2024
Table 367 Bristol-Myers Squibb Company: Deals, January 2021-November 2024
Table 368 Novartis AG: Company Overview
Table 369 Novartis AG: Products Offered
Table 370 Novartis AG: Product Launches and Approvals, January 2021-November 2024
Table 371 Novartis AG: Deals, January 2021-November 2024
Table 372 Astrazeneca: Company Overview
Table 373 Astrazeneca: Products Offered
Table 374 Astrazeneca: Product Launches and Approvals, January 2021-November 2024
Table 375 Astrazeneca: Deals, January 2021-November 2024
Table 376 Abbvie Inc.: Company Overview
Table 377 Abbvie Inc.: Products Offered
Table 378 Abbvie Inc.: Product Launches and Approvals, January 2021-November 2024
Table 379 Abbvie Inc.: Deals, January 2021-November 2024
Table 380 Abbvie Inc.: Expansions, January 2021-November 2024
Table 381 Lilly: Company Overview
Table 382 Lilly: Products Offered
Table 383 Lilly: Product Launches and Approvals, January 2021-November 2024
Table 384 Lilly: Deals, January 2021-November 2024
Table 385 Pfizer Inc.: Company Overview
Table 386 Pfizer Inc.: Products Offered
Table 387 Pfizer Inc.: Product Launches and Approvals, January 2021-November 2024
Table 388 Pfizer Inc.: Deals, January 2021-November 2024
Table 389 Sarepta Therapeutics, Inc.: Company Overview
Table 390 Sarepta Therapeutics, Inc.: Products Offered
Table 391 Sarepta Therapeutics, Inc.: Product Launches and Approvals, January 2021-November 2024
Table 392 Sarepta Therapeutics, Inc.: Deals, January 2021-November 2024
Table 393 Vertex Pharmaceuticals Incorporated: Company Overview
Table 394 Vertex Pharmaceuticals Incorporated: Products Offered
Table 395 Vertex Pharmaceuticals Incorporated: Product Launches and Approvals, January 2021-November 2024
Table 396 Vertex Pharmaceuticals Incorporated: Deals, January 2021-November 2024
Table 397 Gsk PLC.: Company Overview
Table 398 Gsk PLC.: Products Offered
Table 399 Gsk PLC.: Product Launches and Approvals, January 2021-November 2024
Table 400 Gsk PLC.: Deals, January 2021-November 2024
Table 401 Sanofi: Company Overview
Table 402 Johnson & Johnson Services, Inc.: Company Overview
Table 403 Amgen Inc.: Company Overview
Table 404 Merck KGaA: Company Overview
Table 405 Alnylam Pharmaceuticals, Inc.: Company Overview
Table 406 Incyte: Company Overview
Table 407 Arup Laboratories: Company Overview
Table 408 Devyser: Company Overview
Table 409 Diasorin S.P.A.: Company Overview
Table 410 Tempus: Company Overview
Table 411 Pillar Biosciences Inc.: Company Overview
Table 412 Invivoscribe, Inc.: Company Overview
Table 413 Neurocode: Company Overview
Table 414 C2N Diagnostics: Company Overview
Table 415 Trinity Biotech: Company Overview
Table 416 Amoy Diagnostics Co. Ltd.: Company Overview

Figure 1 Precision Diagnostics and Medicine Market Segmentation
Figure 2 Precision Diagnostics and Medicine Market: Research Design
Figure 3 Precision Diagnostics and Medicine Market: Breakdown of Primary Interviews
Figure 4 Precision Diagnostics Market Size Estimation: Supply-Side Analysis
Figure 5 Precision Diagnostics Market Size Estimation: Revenue Share Analysis
Figure 6 Illustrative Example of F. Hoffmann-La Roche Ltd.: Revenue Share Analysis, 2023
Figure 7 Precision Medicine Market Size Estimation: Supply-Side Analysis
Figure 8 Precision Medicine Market Size Estimation: Revenue Share Analysis
Figure 9 Illustrative Example of Merck & Co. Inc.: Revenue Share Analysis, 2023
Figure 10 Market Size Validation from Primary Sources
Figure 11 Precision Diagnostics Market Size Estimation Methodology: Top-Down Approach
Figure 12 Precision Medicine Market Size Estimation Methodology: Top-Down Approach
Figure 13 Precision Diagnostics Market: CAGR Projections, 2024-2029
Figure 14 Precision Medicine Market: CAGR Projections, 2024-2029
Figure 15 Precision Diagnostics and Medicine Market: Growth Analysis of Market Dynamics
Figure 16 Precision Diagnostics and Medicine Market: Data Triangulation
Figure 17 Precision Diagnostics Market, by Type, 2024 vs. 2029 (USD Billion)
Figure 18 Precision Diagnostics Market, by Indication, 2024 vs. 2029 (USD Billion)
Figure 19 Precision Diagnostics Market, by End-user, 2024 vs. 2029 (USD Billion)
Figure 20 Precision Medicine Market, by Product, 2024 vs. 2029 (USD Billion)
Figure 21 Precision Medicine Market, by Indication, 2024 vs. 2029 (USD Billion)
Figure 22 Precision Medicine Market, by End-user, 2024 vs. 2029 (USD Billion)
Figure 23 Geographical Snapshot of Precision Diagnostics Market, 2024-2029
Figure 24 Geographical Snapshot of Precision Medicine Market, 2024-2029
Figure 25 Increasing Demand for Quick and Accurate Diagnostic Tests to Drive Precision Diagnostics Market
Figure 26 Increasing Number of Regulatory Approvals for Personalized Medicines to Drive Precision Medicine Market
Figure 27 Genetic Testing Segment and US Accounted for Largest Shares of Precision Diagnostics Market in 2023
Figure 28 Oncology Segment to Have Largest Market Share During Forecast Period
Figure 29 Home Care Settings Market Commanded Highest Share in 2023
Figure 30 Monoclonal Antibodies and US Led North American Precision Medicine Market in 2023
Figure 31 Oncology Segment to Dominate Market During Forecast Period
Figure 32 Japan to Register Highest Growth in Precision Diagnostics Market During Forecast Period
Figure 33 Germany to Register Highest Growth in Precision Medicine Market During Forecast Period
Figure 34 Precision Diagnostics and Medicine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 35 Revenue Shift and New Revenue Pockets for Players in Precision Diagnostics and Medicine Market
Figure 36 Average Selling Price Trend of Precision Diagnostic Tests, by Key Player, 2021-2023 (USD)
Figure 37 Average Selling Price Trend of Precision Medicine Products, by Key Player, 2021-2023 (USD)
Figure 38 Average Selling Price Trend of Precision Medicine Products, by Region, 2021-2023 (USD)
Figure 39 Precision Diagnostics Market: Value Chain Analysis
Figure 40 Precision Medicine Market: Value Chain Analysis
Figure 41 Precision Diagnostics Market: Supply Chain Analysis
Figure 42 Precision Medicine Market: Supply Chain Analysis
Figure 43 Precision Diagnostics and Medicine Market: Ecosystem Analysis
Figure 44 Precision Diagnostics and Medicine Market: Patent Analysis, January 2014-November 2024
Figure 45 Precision Diagnostics Market: Porter's Five Forces Analysis
Figure 46 Precision Medicine Market: Porter's Five Forces Analysis
Figure 47 Influence of Stakeholders on Buying Process of Precision Diagnostic Products, by Type
Figure 48 Influence of Stakeholders on Buying Process of Precision Medicine Products, by Product
Figure 49 Key Buying Criteria for Precision Diagnostic Products, by End-user
Figure 50 Key Buying Criteria for Precision Medicine Products, by End-user
Figure 51 North America: Precision Diagnostics and Medicine Market Snapshot
Figure 52 Europe: Precision Diagnostics and Medicine Market Snapshot
Figure 53 Precision Diagnostics Market: Revenue Analysis of Key Players, 2021-2023 (USD Million)
Figure 54 Precision Medicine Market: Revenue Analysis of Key Players, 2021-2023 (USD Million)
Figure 55 Precision Diagnostics Market Share Analysis of Key Players, 2023
Figure 56 Precision Diagnostics Market Share Analysis of Key Players, 2023
Figure 57 Precision Diagnostics Market: Company Evaluation Matrix (Key Players), 2023
Figure 58 Precision Diagnostics Market: Company Footprint
Figure 59 Precision Medicine Market: Company Evaluation Matrix (Key Players), 2023
Figure 60 Precision Medicine Market: Company Footprint
Figure 61 Precision Diagnostics Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 62 Precision Medicine Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 63 Precision Diagnostics Market: Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors, 2024
Figure 64 Precision Diagnostics Market: EV/EBITDA of Key Vendors, 2024
Figure 65 Precision Medicine Market: Year-To-Date (Ytd) Price Total Return and 5-Year Stock Beta of Key Vendors, 2024
Figure 66 Precision Medicine Market: EV/EBITDA of Key Vendors, 2024
Figure 67 Precision Diagnostics Market: Brand/Product Comparison
Figure 68 Precision Medicine Market: Brand/Product Comparison
Figure 69 F. Hoffmann-La Roche Ltd (Diagnostics): Company Snapshot (2023)
Figure 70 Abbott: Company Snapshot (2023)
Figure 71 Agilent Technologies, Inc.: Company Snapshot (2023)
Figure 72 Guardant Health: Company Snapshot (2023)
Figure 73 Exact Sciences Corporation: Company Snapshot (2023)
Figure 74 Qiagen: Company Snapshot (2023)
Figure 75 Myriad Genetics, Inc.: Company Snapshot (2023)
Figure 76 Natera, Inc.: Company Snapshot (2023)
Figure 77 Illumina, Inc.: Company Snapshot (2023)
Figure 78 Thermo Fisher Scientific Inc.: Company Snapshot (2023)
Figure 79 Danaher: Company Snapshot (2023)
Figure 80 23Andme, Inc.: Company Snapshot (2023)
Figure 81 Merck & Co. Inc.: Company Snapshot (2023)
Figure 82 Gilead Sciences, Inc.: Company Snapshot (2023)
Figure 83 F. Hoffmann-La Roche Ltd (Medicine): Company Snapshot (2023)
Figure 84 Bristol-Myers Squibb Company: Company Snapshot (2023)
Figure 85 Novartis AG: Company Snapshot (2023)
Figure 86 Astrazeneca: Company Snapshot (2023)
Figure 87 Abbvie Inc.: Company Snapshot (2023)
Figure 88 Lilly: Company Snapshot (2023)
Figure 89 Pfizer Inc.: Company Snapshot (2023)
Figure 90 Sarepta Therapeutics, Inc.: Company Snapshot (2023)
Figure 91 Vertex Pharmaceuticals Incorporated: Company Snapshot (2023)
Figure 92 Gsk PLC.: Company Snapshot (2023)